NASDAQ:ETHZ Flag Ship Acquisition Q1 2025 Earnings Report $4.87 +0.10 (+2.10%) As of 06/3/2026 ProfileEarnings HistoryForecast Flag Ship Acquisition EPS ResultsActual EPS-$6.70Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AFlag Ship Acquisition Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AFlag Ship Acquisition Announcement DetailsQuarterQ1 2025Date5/15/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Flag Ship Acquisition Earnings HeadlinesETHZilla Becomes Forum in Next Step of Strategic Evolution Toward Institutional-Grade Real-World Asset TokenizationFebruary 25, 2026 | prnewswire.comETHZilla Announces First Ever Tradable Tokenized Aviation Assets on Ethereum Network Secured by Jet Engines on Lease with a Leading U.S. Air CarrierFebruary 12, 2026 | prnewswire.com9 days.SpaceX is set to price on June 12 in what could be the largest IPO in history at a $1.75 trillion valuation. Before that happens, analyst Dylan Jovine says there's one small, publicly traded company that Musk's entire empire depends on - and it's still dirt cheap. Once the S-1 hits and every fund and financial journalist starts digging, this window closes. Jovine is releasing the name and ticker today.June 4 at 1:00 AM | Behind the Markets (Ad)ETHZilla Purchases Manufactured Home Loan Portfolio, Plans Tokenization on Ethereum L2February 5, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ETHZilla Corporation - ETHZJanuary 22, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ETHZilla Corporation - ETHZJanuary 20, 2026 | globenewswire.comSee More Flag Ship Acquisition Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Flag Ship Acquisition? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Flag Ship Acquisition and other key companies, straight to your email. Email Address About Flag Ship Acquisition1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.View Flag Ship Acquisition ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro in FocusMedtronic Bottoms, Healthy Rebound AheadFrom Runway to Riches: Victoria's Secret's New LookDell's AI Toll Bridge Is Paved with Record MarginsGitLab’s Price Recovery Gains Traction—Time to Get On Board?Ulta's Q1 Report Primes It for a Beauty of a ReboundPalo Alto Networks Accelerates Growth 31% on AI Demand Upcoming Earnings Oracle (6/10/2026)Adobe (6/11/2026)Accenture (6/18/2026)FedEx (6/23/2026)Micron Technology (6/24/2026)NIKE (6/30/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
